Expression of concern
Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1
Paper Information
Record ID:
24684
Author(s):
Journal:
Publication Date:
July 10, 2019
Retraction Date:
May 29, 2020
(5.5 years years ago)
Subjects:
Institutions:
- Department of Gynecology, Jining No. 1 People’s Hospital, Jining, Shandong, China
- Department of Interventional Radiology, Qingdao Hospital of Traditional Chinese Medicine, Qingdao, Shandong, China
- Department of Interventional Radiology, Jinan Military General Hospital, Jinan, Shandong, China
- Department of Interventional Radiology, Jining No. 2 People’s Hospital, Jining, Shandong, China
- Department of Oncology, Qingdao Hospital of Traditional Chinese Medicine, Renmin Road 4, Qingdao, 266000, Shandong, China
- Department of Gynecology, Qingdao Hospital of Traditional Chinese Medicine, Renmin Road 4, Qingdao, 266000, Shandong, China
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Springer
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reasons:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1007/s00210-019-01687-2Citations (11)
11
Total Citations7
Post-Retraction(63.6%)
3
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
3
Within 1 year
2
After 2+ years
1378
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Cardenolide glycosides sensitize gefitinib-induced apoptosis in non-small cell lung cancer: inhibition of Na+/K+-ATPase serving as a switch-on mechanism
Chimin Du, Wohn‐Jenn Leu, Yi‐Huei Jiang et al. (9 authors)
Naunyn-Schmiedeberg s Archives of Pharmacology
Published: Mar 2024
1 citation
1 citation
1378 days after retraction
Cinobufacini suppresses malignant behaviors of endometrial cancer by regulating NF-κB pathway
Mengyi Sun, Xiaodao Han, Xiaoyun Liu et al. (4 authors)
Biotechnology and Genetic Engineering Reviews
Published: Apr 2023
1 citation
1 citation
1042 days after retraction
Enhancement of Dissolving Capacity and Reducing Gastric Mucosa Irritation by Complex Formation of Resibufogenin with β-Cyclodextrin or 2-Hydroxypropyl-β-cyclodextrin
Nan Liu, Huan-Ping Chen, Zimeng Yang et al. (7 authors)
Molecules
Open Access
Published: May 2022
3 citations
3 citations
718 days after retraction
Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy
Shan Wang, Jialei Fu, Huifeng Hao et al. (6 authors)
Pharmacological Research
Published: Jun 2021
148 citations
148 citations
378 days after retraction
The role of pyroptosis in lung cancer and compounds regulated pyroptosis of lung cancer cells
Feng Tian, Xueyang Chen, Ke Yin et al. (5 authors)
Journal of Cancer Research and Therapeutics
Open Access
Published: Jan 2021
7 citations
7 citations
217 days after retraction
Retraction Note to: Resibufogenin suppresses tumor growth and inhibits glycolysis in ovarian cancer by modulating PIM1
Qian Li, Chuanwu Jiang, Yan Wang et al. (12 authors)
Naunyn-Schmiedeberg s Archives of Pharmacology
Open Access
Published: Nov 2020
1 citation
1 citation
181 days after retraction
Temperature-sensitive gel-loaded composite nanomedicines for the treatment of cervical cancer by vaginal delivery
Sujuan Zhang, Yongtai Zhang, Zhi Wang et al. (9 authors)
International Journal of Pharmaceutics
Published: Jul 2020
18 citations
18 citations
39 days after retraction
<i>RETRACTED:</i> Resibufogenin suppresses growth and metastasis through inducing <scp>caspase‐1‐dependent</scp> pyroptosis via <scp>ROS‐mediated NF‐κB</scp> suppression in <scp>non‐small</scp> cell lung cancer
Hui Yin, Yange Liu, Fei Li et al. (8 authors)
The Anatomical Record
Open Access
Published: May 2020
22 citations
22 citations
17 days before retraction
RETRACTED ARTICLE: Resibufogenin suppresses tumor growth and Warburg effect through regulating miR-143-3p/HK2 axis in breast cancer
Ying Guo, Fei Liang, Zhao Fuli et al. (4 authors)
Molecular and Cellular Biochemistry
Published: Jan 2020
47 citations
47 citations
119 days before retraction
<i>RETRACTED:</i> Resibufogenin inhibited colorectal cancer cell growth and tumorigenesis through triggering ferroptosis and ROS production mediated by GPX4 inactivation
Lian‐Dong Shen, Wen‐Hai Qi, Jiang‐Jiang Bai et al. (10 authors)
The Anatomical Record
Open Access
Published: Jan 2020
55 citations
55 citations
129 days before retraction
Related Records
This article has multiple records in the database due to different notices:
Record #24683
Nov 26, 2020Quick Stats
Total Citations:
11
Years Since Retraction:
5.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025